Clinical Properties of COVID-19 Developed in the Patients with Tuberculosis

Basit Öğe Kaydı
dc.authoridTanriverdi, Elif Seren/0000-0002-0449-0356
dc.authoridOtlu, Baris/0000-0002-6220-0521
dc.authorwosidTanriverdi, Elif Seren/ABE-4472-2021
dc.contributor.authorOtlu, Baris
dc.contributor.authorYakupogullari, Yusuf
dc.contributor.authorTanriverdi, Elif Seren
dc.contributor.authorBentli, Recep
dc.date.accessioned2024-08-04T20:10:15Z
dc.date.available2024-08-04T20:10:15Z
dc.date.issued2022
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThere are limited publications about the Coronavirus disease 19 (COVID-19) clinic developing in the patients with active tuberculosis (TB). In this study, it was aimed to determine some clinical features of patients diagnosed with TB who also had COVID-19. In this retrospective cross-sectional study, 71 pa- tients with COVID-19 were evaluated out of a total of 595 patients diagnosed with TB in our province between 2015 and 2021. After contracting COVID-19, a total of nine (12.6%) TB patients were hospital- ized, five (7%) patients were admitted to the intensive care unit, three (4.2%) were intubated, and one (1.4%) died due to severe COVID-19. The frequency of such health problems was found to be higher than the normal population living in the same province. None of these complications were observed in a total of 40 female TB patients, and the hospital and intensive care unit admission rates for men were significantly higher than for women. The results of this study showed that men with active TB had more health problems due to COVID-19 than the normal population. Comprehensive studies are needed to detail the resilience of female TB patients against COVID-19.en_US
dc.identifier.doi10.5578/mb.20229609
dc.identifier.endpage728en_US
dc.identifier.issn0374-9096
dc.identifier.issue4en_US
dc.identifier.pmid36458717en_US
dc.identifier.scopus2-s2.0-85143184850en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage722en_US
dc.identifier.trdizinid1135563en_US
dc.identifier.urihttps://doi.org/10.5578/mb.20229609
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/1135563
dc.identifier.urihttps://hdl.handle.net/11616/92685
dc.identifier.volume56en_US
dc.identifier.wosWOS:000878101400012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherAnkara Microbiology Socen_US
dc.relation.ispartofMikrobiyoloji Bultenien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectMycobacterium tuberculosisen_US
dc.subjectactive tuberculosisen_US
dc.subjectSARS-CoV-2en_US
dc.subjectCOVID-19en_US
dc.subjectclinical outcomesen_US
dc.titleClinical Properties of COVID-19 Developed in the Patients with Tuberculosisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu